Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in "non-critically-ill" patients on hemodialysis

J Nephrol. 2021 Feb;34(1):259-262. doi: 10.1007/s40620-020-00872-4. Epub 2020 Sep 30.

¹ Department of Medical and Surgical Sciences, Nephrology, Dialysis and Transplantation Unit, University of Foggia, Viale Luigi Pinto, 1, 71100, Foggia, Italy. [email protected].
² Department of Medical and Surgical Sciences, Nephrology, Dialysis and Transplantation Unit, University of Foggia, Viale Luigi Pinto, 1, 71100, Foggia, Italy.
³ Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, Italy.
⁴ Liver Unit, Centro Universitario Per La Ricerca E La Cura Delle Epatopatie (C.U.R.E.), Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

^# Contributed equally.

No abstract available

Keywords: COVID-19; Dialysis; IL-6; Tocilizumab.

Publication types